Apellis Pharmaceuticals (1JK.STU) Q1 2026 Earnings

24FebConfirmed
Q1 2026
-0.4
-0.37
-0.34
-0.32

Details

Expected EPS
-0.317533641
Actual EPS
-0.39902999999999994
Surprise EPS
-0.08
Surprise Percent
+25.67%

Description

Apellis Pharmaceuticals (1JK.STU) has reported earnings of -0.39902999999999994 per share for Q1 2026.

0 Comments

Share your thoughts